Stay updated on Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, representing a maintenance update to the page without altering study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-11T12:54:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.3 to v3.6.4, indicating a minor backend or CMS update without altering study information displayed to users.
    Difference
    0.0%
    Check dated 2026-07-28T05:19:24.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision now shows v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's documentation/versioning rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-07-06T16:32:39.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a maintenance update to the study record page. This reflects a system-level update rather than any changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-06-29T08:31:14.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Recruitment is now listed as 'No longer looking for participants', indicating that enrollment is closed. The page also adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment header formatting along with a revision note.
    Difference
    0.4%
    Check dated 2026-06-15T08:11:14.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing v3.5.4. This reflects a page revision update and does not change the study details or results.
    Difference
    0.0%
    Check dated 2026-06-08T04:30:26.000Z thumbnail image

Stay in the know with updates to Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.